Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Submitted by
admin
on June 23, 2017 - 3:35pm
Source:
Fierce Pharma
News Tags:
Novartis
FDA
Tafinlar
Mekinist
non-small cell lung cancer
BRAF V600
Headline:
Novartis picks up FDA approval for targeted lung cancer meds Tafinlar, Mekinist
Do Not Allow Advertisers to Use My Personal information
